Investing27d
FDA approves Omvoh for Crohn's disease treatment
a significant aspect of Crohn's disease pathology. The FDA's decision is based on results from the Phase 3 VIVID-1 trial, where Omvoh demonstrated effectiveness in achieving clinical remission and ...
Investing26d
FDA approves Omvoh for Crohn's disease treatment
The drug is designed to reduce inflammation in the gastrointestinal tract, a significant aspect of Crohn's disease pathology. The FDA's decision is based on results from the Phase 3 VIVID-1 trial, ...
Medindia4d
Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two years
3 Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020 Dec 31;383(27):2652-2664. doi: 10.1056/NEJMra2002697. PMID: 33382932. 4 Omvoh. Prescribing Information. Lilly USA ...